ARCHIVES

Group Chairman Present A Counter-Proposal To NCI Committee

This article is from The Cancer Letter archive.

Vol. 24 No. 23 | June 12, 1998

Download PDF Visit The Full Archive

Related Articles

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

FDA Approves Implant For Breast Reconstruction

July 26, 2013

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

In Brief: NCI Holding Up Regional Cooperative Group RFA Until Department Approves New Mechanism

February 27, 1981

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003